CF Valencia Life Sciences DST — Form D/A
CF Valencia Life Sciences DST of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2022-11-16. The offering totals $40.4M, of which $40.4M was reported sold. Industry: Other Real Estate.
Offering
- Filed: 2022-11-16
- Form: D/A
- Accession: 0001880053-22-000001
- Industry: Other Real Estate
- Exemptions: 06b
- Total offering: $40.4M
- Amount sold: $40.4M
- Minimum investment: $250K
- Investors: 102
- Date of first sale: 2021-07-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-411232
Issuer
- Name: CF Valencia Life Sciences DST
- CIK: 0001880053
- Entity type: Other
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Phone: 855-922-6867
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| N/A Cantor Fitzgerald Investors, LLC | Executive Officer | New York, NY |
| n/a CF Valencia Life Sciences Depositor, LLC | Executive Officer | New York, NY |
| n/a CF Valencia Life Sciences DST Manager, LLC | Executive Officer | New York, NY |
| Christopher Milner | Executive Officer | NEW YORK, NY |
Other filings by this issuer (1)
More